Dexcom (DXCM) Other Non Operating Income (2010 - 2026)

Dexcom (DXCM) has 12 years of Other Non Operating Income data on file, last reported at $14.2 million in Q1 2026.

• On a quarterly basis, Other Non Operating Income fell 31.07% year-over-year to $14.2 million in Q1 2026; TTM through Mar 2026 was $170.2 million, a 73.32% increase from a year earlier, with the FY2025 full-year figure at $176.6 million, up 62.02% from the prior year.
• Other Non Operating Income for Q1 2026 stood at $14.2 million, down from $17.7 million in the prior quarter.
• Over the last five years, Other Non Operating Income for DXCM reached as high as $109.8 million in Q3 2025 and fell as low as -$1.3 million in Q3 2022.
• Historically, Other Non Operating Income has averaged $24.8 million across 5 years, with a median of $22.4 million in 2024.
• Across the five-year window, Other Non Operating Income plunged 900.0% in 2022 and jumped 2784.62% in 2023, its largest moves.
• Year by year, Other Non Operating Income stood at $8.0 million in 2022, then soared by 266.25% to $29.3 million in 2023, then slipped by 23.55% to $22.4 million in 2024, then slipped by 20.98% to $17.7 million in 2025, then fell by 19.77% to $14.2 million in 2026.
• Per Business Quant data, the three most recent Other Non Operating Income figures were $14.2 million in Q1 2026, $17.7 million in Q4 2025, and $109.8 million in Q3 2025.